Related Experiment Videos
The role of advanced glycation end products in the development of atherosclerosis
Melpomeni Peppa1, Jaime Uribarri, Helen Vlassara
1Division of Experimental Diabetes and Aging, The Mount Sinai School of Medicine, One Gustave Levy Place, Box 1640, New York, NY 10029, USA. helen.vlassara@mssm.edu
Insights
Advanced glycation end products (AGEs), formed from sugars reacting with proteins and lipids, contribute to atherosclerosis, a major cause of cardiovascular disease (CVD). Research explores dietary AGEs and potential anti-AGE strategies to combat CVD.
Area of Science:
- Cardiovascular Science
- Metabolic Disease Research
- Nutritional Biochemistry
Background:
- Cardiovascular disease (CVD) is the primary global cause of mortality.
- Atherosclerosis, characterized by arterial plaque buildup, underlies most CVD cases.
- Advanced glycation end products (AGEs) are increasingly linked to atherosclerosis development and progression, independent of diabetes.
Purpose of the Study:
- To summarize the role of advanced glycation end products (AGEs) in atherosclerosis.
- To highlight the endogenous and exogenous sources of AGEs.
- To introduce potential therapeutic strategies targeting AGEs.
Main Methods:
- Review of existing scientific literature on AGEs and atherosclerosis.
- Analysis of the biochemical pathways involved in AGE formation.
- Examination of dietary contributions to AGE accumulation.
Main Results:
- AGEs are formed through non-enzymatic reactions between sugars and biomolecules.
- Both internal (endogenous) and dietary (exogenous) sources contribute to AGE levels.
- Atherosclerosis progression is associated with increased AGEs.
Conclusions:
- Dietary modifications and anti-AGE interventions show promise for managing atherosclerosis.
- Understanding AGE formation mechanisms is crucial for developing effective CVD prevention strategies.
- Targeting AGEs represents a potential therapeutic avenue for cardiovascular disease.
Abstract:
Cardiovascular disease (CVD) is the leading cause of mortality worldwide. Atherosclerosis constitutes the main pattern of cardiovascular disease and leads to thickening of the intima with plaque formation and eventual occlusion of the arterial lumen. A large amount of evidence links advanced glycation end products (AGEs) with the development or progression of atherosclerosis, regardless of the diabetic status. AGEs are a heterogenous group of compounds formed by the nonenzymatic reaction of reducing sugars with proteins, lipids, and nucleic acids. Although AGEs are formed endogenously in the body, diet has recently been recognized as an important exogenous source. An increased understanding of the mechanisms of formation and interaction of AGEs has allowed the development of several potential anti-AGE approaches.
Related Concept Videos
Atherosclerosis I: Introduction
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Peripheral Artery Disease I: Introduction
Inflammation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests